JAMP-Clopidogrel : may contain overweight or underweight tablets
Brand(s)
Last updated
Summary
Product
JAMP-Clopidogrel
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot numbers |
|---|---|---|---|---|---|
| JAMP | JAMP - Clopidogrel 75mg | DIN 02415550 | Tablet | CLOPIDOGREL BISULFATE 75 mg | EG22CGM002 EG22CGM003 EG23CGM001 EG22CGN001 EG23CGN001 EG23CGN002 EG23CGN003 EG23CGN004 EG23CGL001 |
Issue
Affected lots may contain overweight or underweight tablets.
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Related recalls and alerts
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
JAMP PHARMA CORPORATION
1310 Rue Nobel
Boucherville, QC
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type I
Identification number
RA-76004
Get notified
Receive notifications for new and updated recalls and alerts by category.